Keurig Dr Pepper (NYSE:KDP) had its price objective raised by analysts at Morgan Stanley from $30.00 to $32.00 in a research note issued on Friday, BenzingaRatingsTable reports. The brokerage currently has an “equal weight” rating on the stock. Morgan Stanley’s price objective would suggest a potential upside of 4.61% from the stock’s previous close.
KDP has been the subject of a number of other research reports. Citigroup increased their target price on shares of Keurig Dr Pepper from $28.00 to $31.00 and gave the stock a “neutral” rating in a research report on Tuesday, April 28th. SunTrust Banks reiterated a “buy” rating on shares of Keurig Dr Pepper in a research report on Wednesday, April 29th. Jefferies Financial Group increased their target price on shares of Keurig Dr Pepper from $36.00 to $39.00 and gave the stock a “buy” rating in a research report on Monday, July 27th. Barclays reiterated a “buy” rating on shares of Keurig Dr Pepper in a research report on Wednesday, April 29th. Finally, Evercore ISI upgraded shares of Keurig Dr Pepper from an “in-line” rating to an “outperform” rating and set a $35.00 target price for the company in a research report on Monday, June 1st. Four investment analysts have rated the stock with a hold rating and seven have given a buy rating to the company. The stock has an average rating of “Buy” and a consensus price target of $33.63.
NYSE KDP opened at $30.59 on Friday. Keurig Dr Pepper has a 52-week low of $18.98 and a 52-week high of $32.00. The company has a 50-day simple moving average of $29.12 and a 200 day simple moving average of $27.40. The company has a debt-to-equity ratio of 0.52, a quick ratio of 0.23 and a current ratio of 0.31. The company has a market capitalization of $43.04 billion, a PE ratio of 23.71, a price-to-earnings-growth ratio of 1.90 and a beta of 0.61.
Keurig Dr Pepper (NYSE:KDP) last posted its quarterly earnings data on Thursday, July 30th. The company reported $0.33 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.32 by $0.01. The business had revenue of $2.86 billion during the quarter, compared to the consensus estimate of $2.81 billion. Keurig Dr Pepper had a net margin of 10.32% and a return on equity of 7.91%. The firm’s quarterly revenue was up 1.8% compared to the same quarter last year. During the same quarter last year, the company posted $0.30 earnings per share. As a group, analysts forecast that Keurig Dr Pepper will post 1.4 EPS for the current fiscal year.
In related news, major shareholder Holdings B.V. Jab bought 7,380,000 shares of the company’s stock in a transaction on Friday, May 22nd. The stock was acquired at an average cost of $27.16 per share, for a total transaction of $200,440,800.00. Also, Director Robert S. Singer purchased 1,000 shares of the firm’s stock in a transaction on Friday, June 12th. The shares were acquired at an average cost of $28.14 per share, for a total transaction of $28,140.00. Following the completion of the purchase, the director now directly owns 65,500 shares of the company’s stock, valued at approximately $1,843,170. The disclosure for this purchase can be found here. Insiders own 0.41% of the company’s stock.
Several hedge funds have recently bought and sold shares of KDP. Capital International Investors increased its stake in shares of Keurig Dr Pepper by 217.9% in the first quarter. Capital International Investors now owns 21,100,960 shares of the company’s stock worth $512,121,000 after buying an additional 14,463,379 shares during the period. Wellington Management Group LLP raised its position in Keurig Dr Pepper by 14,520.4% in the 1st quarter. Wellington Management Group LLP now owns 7,033,862 shares of the company’s stock worth $170,712,000 after buying an additional 6,985,752 shares during the last quarter. Nuveen Asset Management LLC raised its position in Keurig Dr Pepper by 49.7% in the 1st quarter. Nuveen Asset Management LLC now owns 12,857,766 shares of the company’s stock worth $312,058,000 after buying an additional 4,270,745 shares during the last quarter. Norges Bank purchased a new position in Keurig Dr Pepper in the 4th quarter worth about $120,088,000. Finally, Wells Fargo & Company MN raised its position in Keurig Dr Pepper by 975.6% in the 1st quarter. Wells Fargo & Company MN now owns 2,509,389 shares of the company’s stock worth $60,903,000 after buying an additional 2,276,089 shares during the last quarter. 22.86% of the stock is currently owned by hedge funds and other institutional investors.
Keurig Dr Pepper Company Profile
Keurig Dr Pepper Inc operates as a beverage company in the United States and internationally. It operates through four segments: Beverage Concentrates, Packaged Beverages, Latin America Beverages, and Coffee Systems. The Beverage Concentrates segment manufactures and sells beverage concentrates. This segment also manufactures beverage concentrates into syrup.
Recommended Story: Dividend Reinvestment Plan (DRIP)
Receive News & Ratings for Keurig Dr Pepper Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Keurig Dr Pepper and related companies with MarketBeat.com's FREE daily email newsletter.